OurBrainBank is a completely new approach to cracking cancer. We focus on one of the most complex and aggressive forms of cancer—Glioblastoma—because overcoming one of the toughest cancers offers the most speedy and cost effective way of cracking all cancers.
OurBrainBank is designed with and for people with Glioblastoma. We use cutting-edge technology to enable people to manage their disease, while turning their data into medical currency aimed at accelerating progress in overcoming glioblastoma. Our key tool is the OurBrainBank App which is designed to help people manage their disease as well as provide much-needed data for medical researchers, so together we can beat this disease.
Using a mobile device, download the OurBrainBank App from Google Play or the App Store. You'll be prompted to register (use code OBB100). You must be a GBM patient or caregiver, over 18 years old, and in the United States (we hope to expand abroad soon).
We encourage you to use the app daily—as many times as you want each day—for an initial 100 days. We've chosen 100 days because this gives us sufficient data to produce meaningful results. After that, the OurBrainBank team of medical researches will examine the aggregated data, so we can deepen understanding of the disease, help drive new trials, and develop new insights into the quality of life and experiences of people living with GBM.
As you progress through the initial 100 days, you can view your data at any time by accessing reports via the menu icon in the top left-hand corner of the screen and selecting "my reports." Here you can compare different symptoms and view your progress over time.
You can choose to show your data to other people, including your healthcare team, so they can see how your symptoms as you have reported, have changed over time. This may help deepen you and your clinician's shared understanding of the relationship between your treatments and your symptoms.
The App allows you to self-track your neurological functions, with smart games that test balance, ability to compare numbers, and speed of neurological function. They're quite addictive!
The App can be used to track other health data such as your weight, blood pressure or blood sugar data, if you regularly track these.
There's also a neat journal feature, so you keep a regular note of how you're doing.
After the initial 100 day study, the OurBrainBank team will take stock and analyze the group data from everyone using the App. We plan to publish our findings widely, sharing the insights gleaned from the aggregated data, and driving more research to crack Glioblastoma.
Beyond the initial 100 days, your data will be used to power the on-going OurBrainBank machine. We STRONGLY encourage you to continue to participate after your first 100 days, to 1000 days. Your input is crucial to the success of the mission—to turn GBM from terminal to treatable!
For people living with GBM and their caregivers, the App enables you to better understand disease symptoms over time. For example, many people taking chemotherapy find that there is a pattern to the fatigue associated with the medication cycle. Tracking fatigue daily helps patients plan their activities as it helps alert them to when fatigue is likely to be most burdensome.
Everyone using the App will be asked to consent to have their data used anonymously. The aggregated patient data will be analyzed by Columbia University in New York, and the Dana-Farber Cancer Institute in Boston. Their teams of world-class researchers will examine the data to spot insights and deepen and speed up understanding of GBM.
Because we want to fast-track GBM research, the data will be freely available to any qualified GBM researcher worldwide.
There is no cost to you to participate in this study other than to your mobile data plan if applicable.
Your name will not be available to researchers. It will be removed from all study databases for analysis.
Your personal health information that may be used or disclosed in connection with this research study, will include, but is not limited to your body height, weight, gender, age, ethnicity/race, health history and answers to study questions that you choose to answer.
The study investigators, study coordinators and study staff may use and share your de identified personal information (in other words your identity will not be disclosed) to do the research described (or as required by law).
We will not disclose your identity in any reports about this study such as scientific publications or presentations.
A copy of the data you collect will be sent to a research database for further research, but data that identifies you will be removed. Anyone wanting to use the anonymized data will have to be approved by OurBrainBank.
We are committed to protecting your privacy and to this end the app has been designed to prevent disclosure of your identity and to maintain the confidentiality of users. Except as required by law, you will not be identified by name or by any other direct personal identifier.
To protect your privacy we will use a random code number instead of your name on all your data collected, analyzed, aggregated and released to researchers. Information about the code will be kept in a secure system. Researchers will have access to all the data collected in the study, but will be unable to easily map any particular data to the identities of the participants.
Your de-identified data will be placed in a 'repository' – a secure online database – where approved qualified researchers can access it. It could then be included in large, computational studies related to general health and wellness. The results of this research study may be presented at scientific or medical meetings or published in scientific journals. In all these scenarios, your identity will not be disclosed. As with any online database there is a risk that our database can be breached by hackers. However, our partners uMotif's technology is such that this is very unlikely.
Information about you and your health is personal and private and cannot be used in a research study without your permission (opt-in). This is why we provide an e-consent form as part of signing up to the OurBrainBank App. If you agree to participate in the project, you will provide that permission. But if you do not, you will not be able to participate in this research study.
Please note that researchers will not be able to access any of your identifiable data. They will only be able to use a research dataset where your name and other identifiable information has been removed - known as de-identified or anonymised data.
If you have any questions, please contact firstname.lastname@example.org.
OurBrainBank has been created by people living with Glioblastoma. Our founder is Jessica Morris, who was diagnosed in January 2016. She has built OurBrainBank with her doctor, Fabio Iwamoto MD, Columbia University; Lakshmi Nayak MD, Dana-Farber Cancer Institute, and Bruce Hellman, CEO of uMotif, who designed the OurBrainBank app.
OurBrankBank is a nonprofit organization, with an active board chaired by founder Jessica Morris.
OurBrainBank currently is US-only, we plan to expand internationally.
Join us on Facebook to exchange ideas, symptoms, and support. Participate in video chats, read our newsletter, learn more on our YouTube channel (with helpful "how to" videos), and follow us on Instagram.
OurBrainBank is a nonprofit, funded by individuals, companies, and philanthropies. We welcome donations.
Your participation in this study is voluntary. You may decide not to participate or you may leave the study at any time. Either of these decisions will not result in any penalty.
If you withdraw from the study, we will stop collecting new data and delete your study data from the research servers), but some copies of your data that have already been distributed to qualified researchers will not be able to be destroyed or deleted.
The Project coordinators or the sponsor may also withdraw you from the study without your consent at any time for any reason if you do not consent to continue in the study after being told of changes in the research , or if the study is cancelled.
You can still record your symptoms on the aAp while you are abroad and it will be uploaded when a data connection becomes available – we recommend either you connect to WiFi, enable data roaming on your phone or return to the US. Please note that enabling data roaming while abroad can lead to high costs so check your mobile phone plan and the charges if you want to do this.
As a first step, we invite you to record your symptoms for 100 days. We will then invite you to continue tracking your symptoms, and keep you abreast of how the community of people using the app is doing.
If you want to withdraw from participation please contact us at email@example.com